SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001019056-16-001557
Filing Date
2016-09-27
Accepted
2016-09-27 15:42:42
Documents
1
Period of Report
2016-08-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT lamothe_4a.html 4/A  
1 OWNERSHIP DOCUMENT lamothe_4a.xml 4/A 7898
  Complete submission text file 0001019056-16-001557.txt   9269
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Lamothe Jeffrey G. (Reporting) CIK: 0001679967 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37746 | Film No.: 161904396